Neurology Flashcards
Describe the management of epilepsy
Most neurologists now start antiepileptics following a second epileptic seizure.
NICE guidelines suggest starting antiepileptics after the first seizure if:
> neurological deficit
> brain imaging: structural abnormality
> EEG: unequivocal epileptic activity
> patient / family / carers seizure risk unacceptable
Drug treatment
- Generalised tonic-clonic seizures
> males: sodium valproate
> females: lamotrigine or levetiracetam
» sodium valproate if under 10 or women unable to have children
» sodium valproate causes weight gain - Focal seizures
> first line: lamotrigine or levetiracetam
> second line: carbamazepine, oxcarbazepine or zonisamide - Absence seizures (Petit mal)
> first line: ethosuximide
> second line:
male: sodium valproate
female: lamotrigine or levetiracetam
carbamazepine may exacerbate absence seizures - Myoclonic seizures
> males: sodium valproate
> females: levetiracetam - Tonic or atonic seizures
> males: sodium valproate
> females: lamotrigine
describe autonomic dysreflexia
caused by excessive sympathetic response below level of injury without coordinated parasympathetic counter response
can only occur if spinal cord injury is above T6
features
- severe hypertension
- flushing and sweating above level of injury
- reflex bradycardia
causes
- urinary retention / catheter blockage
- faecal impaction / loading
complications: stroke
describe Guillain-Barré syndrome
immune-mediated demyelination of peripheral nervous system usually post-diarrhoeal illness e.g. Campylobacter jejuni
clinical features
- back/leg pain
- progressive symmetrical ascending weakness (starting in legs)
- reflexes are reduced or absent
- sensory symptoms usually mild
other features
- respiratory muscle weakness
- cranial nerve involvement: diplopia, bilateral facial nerve palsy, oropharyngeal weakness
- autonomic involvement: urinary retention, diarrhoea
investigations
- LP: rise in CSF protein with normal WCC
> gold-standard investigation
- anti-ganglioside antibodies
- Nerve conduction studies: decreased motor nerve conduction velocity
treatment - plasma exchange, IV immunoglobulins
Which medications can be given for the following problems in MS?
- fatigue
- spasticity
- oscillopsia
- bladder dysfunction
fatigue: amantadine
spasticity: baclofen, gabapentin
oscillopsia: gabapentin
bladder dysfunction: anticholinergics
which medications can be given to reduce the risk of relapse in MS?
indications
> relapsing-remitting disease + 2 relapses in past 2 years + able to walk 100m unaided
secondary progressive disease + 2 relapses in past 2 years + able to walk 10m (aided or unaided)
medications
- natalizumab: first-line
- ocrelizumab: another first-line option
- fingolimod
- beta-interferon: less effective
- glatiramer acetate: less effective
describe hereditary sensorimotor neuropathy (HSMN) aka Charcot-Marie-Tooth
encompasses Charcot-Marie-Tooth disease (aka peroneal muscular atrophy)
2 common types in clinical practice
- type I: demyelinating
- type II: axonal pathology
HSMN type I
- Autosomal dominant
- due to defect in myelin-coding gene
- features start at puberty
- motor symptoms predominate
- distal muscle wasting, pes cavus, clawed toes
- foot drop and leg weakness often first features
when can anti-epileptic drugs (AED) be stopped?
can be considered if seizure free for >2 years with AEDs being stopped over 2-3 months
describe localising features of focal seizures
temporal lobe
- with/without impairment of consciousness or awareness
- aura
> rising epigastric sensation
> psychic/experiential phenomena e.g. deja vu, jamais vu - less commonly hallucinations (auditory/gustatory/olfactory)
- seizures typically last around one minute
- automatisms (lip smacking/grabbing/plucking of clothes)
- post-ictal dysphasia
- Todd’s paralysis
frontal lobe (motor)
- head/leg movements
- posturing
- post-ictal weakness
- Jacksonian march
parietal lobe (sensory)
- paraesthesia
occipital lobe (visual)
- floaters/flashes
describe subacute combined degeneration of the cord
SCD: spinocerebellar tract, corticospinal tract, dorsal columns
causes
- vitamin B12 & E deficiency
- can result from replacing folate before b12 if b12 deficient (BeFore)
- nitrous oxide inhalation
features
- bilateral spastic paresis: weakness, spasticity
- bilateral loss of proprioception and vibration
- distal tingling, burning and/or sensory loss
- bilateral limb ataxia
- hyperreflexia
- positive Babinski sign
positive Romberg’s test due to sensory ataxia
list driving restrictions for individuals with epilepsy
first unprovoked/isolated seizure: 6 months off if no structural brain abnormalities on imaging or epileptiform activity on EEG
established epilepsy / multiple unprovoked seizures:
> qualify for driving license if they have been seizure free for 12 months
> if no seizures for 5 years, a til 70 license is restored
withdrawal of epilepsy medication: cannot drive whilst being withdrawn and for 6 months after
describe spinal muscular atrophy (SMA)
rare autosomal recessive condition which causes a progressive loss of lower motor neurones leading to progressive muscular weakness
features
- fasciculations
- reduced muscle bulk
- reduced tone
- reduced power
- reduced / absent reflexes
management: supportive
describe myotonic dystrophy
genetic disorder usually presenting in adulthood
features
- progressive muscle weakness
- prolonged muscle contractions
- cataracts
- cardiac arrhythmias
describe the features, investigations and management of a TIA
brief period of neurological deficit due to a vascular cause, typically lasting less than an hour (always <24h)
Clinical features
- unilateral weakness or sensory loss
- aphasia or dysarthria
- ataxia, vertigo, or loss of balance
- visual problems
- sudden transient loss of vision in one eye (amaurosis fugax)
- diplopia
- homonymous hemianopia
ABCD2: prognostic score to risk stratify patients
Management
- immediate antithrombotic therapy: > aspirin 300 mg immediately
unless:
1. bleeding disorder / anticoagulated (needs immediate admission for imaging to exclude a haemorrhage)
2. already taking low-dose aspirin regularly: continue the current dose of aspirin until reviewed by a specialist
3. Aspirin is contraindicated: discuss management urgently with the specialist team
Advise the person not to drive until they have been seen by a specialist
Investigations
- diffusion-weighted MRI first-line
- Carotid imaging
> all patients should have an urgent carotid doppler unless they are not a candidate for carotid endarterectomy
Further management
> Secondary prevention
- clopidogrel is recommended first-line (as for patients who’ve had a stroke)
- aspirin + dipyridamole should be given to patients who cannot tolerate clopidogrel
- lipid modification
- high-intensity statin (such as atorvastatin 20–80 mg daily)
carotid artery endarterectomy if carotid stenosis > 70%
Describe the symptoms of stroke depending on the affected vessel
ACA
> contralateral hemiparesis and sensory loss
> lower extremity > upper
MCA
> contralateral hemiparesis and sensory loss
> upper extremity > lower extremity
> aphasia
> contralateral homonymous hemianopia
PCA
> Contralateral homonymous hemianopia with macular sparing
> Visual agnosia
Weber’s syndrome (branches of PCA supplying midbrain)
> contralateral upper and lower limb weakness
> ipsilateral CN III palsy
PICA (lateral medullary syndrome, Wallenberg syndrome)
> ipsilateral facial pain and temperature loss
> contralateral limb/torso pain and temperature loss
> ataxia, nystagmus
> ipsilateral Horner’s syndrome
AICA (lateral pontine syndrome)
> similar to Wallenberg’s but ipsilateral facial paralysis and deafness also
> reduced GCS, paralysis, bilateral pinpoint pupils
Retinal/ophthalmic artery: amaurosis fugax
Basilar artery: locked in syndrome
Lacunar strokes present with either isolated hemiparesis, hemisensory loss or hemiparesis with limb ataxia
> strong association with hypertension
> common sites include the basal ganglia, thalamus and internal capsule
Describe bacterial meningitis and its management
Clinical features
- meningism: neck stiffness, photophobia
- nausea / vomiting
- reduced GCS
- non-blanching rash
- fever
- tachycardia, tachypnoea, hypotension
- Brudzinski / kernig’s sign +ve
attempt LP unless
- severe sepsis / rapidly evolving rash
- severe respiratory / cardiac compromise
- significant bleeding risk
- signs of raised ICP (focal neurological signs, papilloedema, continuous/uncontrolled seizures)
CT head prior to LP ONLY if risk of evolving SOL / signs of increased ICP
Management
- IV antibiotics
> <3 months: IV cefotaxime + amoxicillin
> 3 months-50 years: cefotaxime or ceftriaxone
> >50 years: cefotaxime (or ceftriaxone) + amoxicillin (increased risk of Listeria meningitis)
- IV dexamethasone 0.15mg/kg QDS for 4 days
> avoid in septic shock, meningococcal septicaemia, immunocompromised or meningitis following surgery - if allergic to penicillin / cephalosporins, use chloramphenicol
- if Listeria monocytogenes: IV amoxicillin + gentamicin
Describe a post-LP headache and its management
Low pressure headache
can occur up to a week later from when the LP was taken
alleviated by lying down
> if headache lasts more than 3 days, consider subdural haematoma
management
- supportive analgesia - analgesia, rest
- consider blood patch, epidural saline and IV caffeine
Describe the diagnostic criteria for migraine
- headache attacks lasting 4-72h
- at least 2 of the following characteristics
> unilateral location but may be bilateral
> pulsating quality
> moderate or severe pain
> aggravation by routine physical activity - during headache at least one of the following
> nausea or vomiting
> photophobia, phonophobia - not attributed to another disorder
in children, attacks may be shorter-lasting, headache is bilateral and GI disturbance is more prominent
migraine with aura
> aura is progressive in nature and occurs hours prior to headache
> typical aura: transient hemianopic disturbance / spreading scintillating scotoma (jagged crescent)
> sensory symptom
auras may occur with/without headache and are fully reversible, develop over at least 5 minutes and last 5-60 minutes
atypical symptoms
> motor weakness
> double vision
> visual symptoms affecting only one eye
> poor balance / decreased GCS
Name the most common cause of
- bacterial meningitis <60
- viral meningitis
- viral encephalitis
bacterial meningitis <60: Neisseria meningitidis, streptococcus pneumoniae
Viral meningitis: enterovirus
> Coxsackie, Echovirus
Viral encephalitis: HSV
Describe viral meningitis and its management
Presents similarly to bacterial meningitis
> less likely to have a non-blanching purpuric rash
> less severe than bacterial meningitis
management
- supportive, usually self-limiting course of 7-14 days
- aciclovir if thought to be caused by HSV
- IV aciclovir if concern regarding encephalitis
in the context of meningitis, under which circumstances should LP be delayed?
- signs of severe sepsis
- rapidly evolving rash
- severe respiratory / cardiac compromise
- significant bleeding risk
- signs of increased ICP
> focal neurology
> GCS <=12
> Papilloedema
> seizures
describe CSF results depending on the cause of meningitis
bacterial
- appearance: cloudy
- glucose: low (<1/2 plasma)
- protein: high (>1g/l)
- WCC: 10-5000 polymorphs/mm3
viral
- appearance: clear/cloudy
- glucose: 60-80% of plasma glucose
- protein: normal/raised
- WCC: 15-1000 lymphocytes/mm3
TB
- appearance: slight cloudy, fibrin web
- glucose: low (<1/2 plasma)
- protein: high (>1 g/l)
- WCC: 30-300 lymphocytes/mm3
fungal
- appearance: cloudy
- glucose: low
- protein: high
- WCC: 20-200 lymphocytes/mm3
describe the management of status epilepticus
- ABCDE assessment
- airway: lateral decubitus, nasal trumpets, O2, suction
- IV access
0-5 mins (give benzos at 5 mins)
> lorazepam 0.1mg/kg IV, max 4mg, repeat once in 4min
> OR midazolam 10mg IM once
10-15 mins
> levetiracetam 60mg/kg IV
> OR fosphenytoin or phenytoin 20mg/kg IV
> OR valproate 40mg/kg IV
> advanced airway management
> RSI
> Preoxygenation
> Induction: propofol or ketofol
> paralytics: rocuronium, succinylcholine
15-20 mins: refractory medications
- propofol
- midazolam
- ketamine
- lacosamide
- phenobarbital
describe herpes simplex encephalitis
infection of brain parenchyma
features
- fever
- headache
- psychiatric symptoms
- seizures
- vomiting
- focal features e.g. aphasia, weakness, limping
investigations
- LP
> elevated protein
> lymphocytosis
> PCR for HSV, VZV, enterovirus
- CT head: temporal lobe changes e.g. asymmetrical low density areas
- EEG
management
- start aciclovir promptly in all suspected cases of viral encephalitis
> treats HSV and VZV
> ganciclovir is needed for CMV
how would you check if fluid is truly CSF?
check a glucose level: bedside test
beta-2-transferrin level: gold standard